Overeating: Treatment of Obesity and Anxiety by Auricular Acupuncture, An Analysis of 800 Cases

1996 ◽  
Vol 14 (2) ◽  
pp. 116-120 ◽  
Author(s):  
A Apostolopoulos ◽  
M Karavis
Keyword(s):  
Weight Loss ◽  
Acupuncture Point ◽  
Control Programme ◽  
The Body ◽  
Auricular Acupuncture ◽  
Significant Weight Loss ◽  
Treatment Of Obesity ◽  
Psychological Balance ◽  
One Year ◽  
Group B

Auricular acupuncture (placement of press needles) was applied at the stomach point (according to Nogier) and sometimes at the point of psychological balance (Shenmen) for the control of anxiety and for help in weight loss in 800 patients over a two year period. Press needles were inserted and left in for 10 to 15 days at the auricular acupuncture point and resited again after 4 to 5 days. At the same time, instructions were given for the standard treatment of obesity (information leaflet, low calorie diet, aerobic exercise, behaviour modification, psychological support, etc.). The patients were followed up for a period of one year. The participants were 683 women and 117 men aged between 15 and 76 years. The Body Mass Index (weight/height) was used to determine the degree of obesity, and cases were divided into three groups according to the number of acupuncture sessions as follows: 468 patients (Group A) had one acupuncture session, 278 (Group B) 2 to 4 sessions, and 54 (Group C) had over 4 sessions, all conducted at 15 to 20 day intervals. A reduction in overeating was reported by 81.1% of patients, and 46.7% of the 697 patients who had noted anxiety symptoms claimed that treatment had helped in the reduction of anxiety. Regular exercise was encouraged, and started by 43.4% of the 703 who had no such habit. There was no significant weight loss in 35.2% of patients. During the first 3 months there was an overall significant weight loss in 64.8% and 35.5% at 6–12 months. The percentage weight loss was higher in Groups B and C and remained higher at six months and one year after the start of acupuncture treatment. Group B presented a good six month result in 61.2% of patients and a good annual result in 39.1%. In Group C results were 88.9% and 77.8% respectively. The control of overeating and anxiety using auricular acupuncture al the stomach and Shenmen points in this audit has been beneficial. Its correct use in an integrated obesity control programme may prove of significant long tem help.

scholarly journals α-Methyl-L-Tryptophan as a Weight-Loss Agent in Multiple Models of Obesity in Mice

2021 ◽  
Author(s):  
Sathish Sivaprakasam ◽  
Sabarish Ramachandran ◽  
Mohd Omar Faruk Sikder ◽  
Yangzom Doma Bhutia ◽  
Mitchell Wachtel ◽  
...  
Keyword(s):  
Weight Loss ◽  
High Fat Diet ◽  
Amino Acid Profile ◽  
Normal Diet ◽  
The Body ◽  
Multiple Models ◽  
High Fat ◽  
Liver And Kidney ◽  
Obesity In Mice ◽  
Treatment Of Obesity

a-Methyl-L-tryptophan (a-MLT) is currently in use as a tracer in its 11C-labeled form to monitor the health of serotonergic neurons in humans. In the present study, we found this compound to function as an effective weight-loss agent at pharmacological doses in multiple models of obesity in mice. The drug was able to reduce the body weight when given orally in drinking water (1 mg/ml) in three different models of obesity: normal mice on high-fat diet, Slc6a14-null mice on high-fat diet, and ob/ob mice on normal diet. Only the L-enantiomer (a-MLT) was active while the D-enantiomer (a-MDT) had negligible activity. The weight-loss effect was freely reversible, with the weight gain resuming soon after the withdrawal of the drug. All three models of obesity were associated with hyperglycemia, insulin resistance, and hepatic steatosis; a-MLT reversed these features. There was a decrease in food intake in the treatment group. Mice on a high-fat diet showed decreased cholesterol and protein in the serum when treated with a-MLT; there was however no evidence of liver and kidney dysfunction. Plasma amino acid profile indicated a significant decrease in the levels of specific amino acids, including tryptophan; but the levels of arginine were increased. We conclude that a-MLT is an effective, reversible, and orally active drug for the treatment of obesity and metabolic syndrome.

scholarly journals Zenker’s diverticulum in an 85-year-old Ugandan man

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Senai Goitom Sereke ◽  
Felix Bongomin ◽  
Zeridah Muyinda
Keyword(s):  
Weight Loss ◽  
Clinical Suspicion ◽  
Zenker’S Diverticulum ◽  
Barium Swallow ◽  
Significant Weight Loss ◽  
Inexpensive Method ◽  
Case Presentation ◽  
Zenker's Diverticulum ◽  
Proximal Esophagus ◽  
One Year

Abstract Background Zenker’s diverticulum (ZD) is an uncommon disorder due to an outpouching of tissue through the Killian triangle that is thought to be caused by dysfunction of the cricopharyngeal muscle. Case presentation An 85-year-old male patient presented with odynophagia and dysphagia of initially solid food followed by fluids that was associated with a significant weight loss over a one-year period. Barium swallow videofluoroscopy demonstrated a posterior outpouching of proximal esophagus that was 2 cm from the epiglottis. With the diagnosis of medium sized ZD, the patient underwent endoscopy guided diverticulotomy. Six months after the procedure, he was asymptomatic and had gained weight. Conclusions Dysphagia and weight loss raises a clinical suspicion for a malignancy. Barium swallow examination is an inexpensive method for the diagnosis of ZD.

scholarly journals Weight loss promoted by the Intra-oral Alimentary Satiety Device in a morbidly obese patient

2015 ◽  
Vol 63 (2) ◽  
pp. 169-174
Author(s):  
Mariane HALMENSCHLAGER ◽  
Alexandre CONDE ◽  
Simara Rufatto CONDE ◽  
Thaís Rodrigues MOREIRA
Keyword(s):  
Weight Loss ◽  
Steel Wire ◽  
Acrylic Resin ◽  
The Body ◽  
Hypocaloric Diet ◽  
Morbidly Obese ◽  
Morbidly Obese Patient ◽  
Dental Acrylic ◽  
Treatment Of Obesity ◽  
Anthropometric Assessment

OBJECTIVE: To evaluate the weight loss fostered by the Intra-oral Alimentary Satiety Device in a patient diagnosed as morbidly obese. METHODS: A female patient diagnosed as morbidly obese who was seeing a nutritionist was examined. Based on her medical history and anthropometric assessment, a hypocaloric diet was prescribed. The nutritional state was assessed by the Body Mass Index (BMI). The patient was advised to wear the Intra-oral Alimentary Satiety Device, and an assessment by a dentist was suggested to discard contraindications. The appliance was then manufactured with dental molding material, orthodontic stainless steel wire, and heat-cured dental acrylic resin. The patient wore the device at every meal, putting it on 5 minutes in advance. For the data analysis the SPSS Statistics 17.0 software was used. RESULTS: In her first consultation, the patient weighed 115 kg and was 1.62 m tall, with BMI = 43.82 Kg/m. Weight loss was 13.3 kg, representing 11.57% of the initial weight. In relation to the BMI, the total loss was 5.06 Kg/m, representing 11.55%. CONCLUSION: The Intra-oral Alimentary Satiety Device can be considered a safe and effective method which, together with a hypocaloric diet, shows satisfactory results, thus proving to be an important auxiliary option in the treatment of obesity.

Nutritional status and outcomes of veterans undergoing curative surgery for colorectal cancer.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e18585-e18585
Author(s):  
Urvashi Mitbander ◽  
Timothy Frankel ◽  
Irina Y. Dobrosotskaya
Keyword(s):  
Colorectal Cancer ◽  
Weight Loss ◽  
Tertiary Care ◽  
Veterans Health ◽  
Health Administration ◽  
Significant Weight Loss ◽  
Curative Surgery ◽  
Curative Intent ◽  
Post Surgery ◽  
One Year

e18585 Background: Malnutrition is highly prevalent within the cancer population. Malnourishment has various negative surgical and oncologic impacts. The Veterans Health Administration (VHA) provides comprehensive care to patients in a single-payer system allowing for capture of peri-operative data and the opportunity for focused pre-operative (pre-op) interventions to improve outcomes. We sought to study the effect of pre-op weight and albumin on post-operative (post-op) complications in a contemporaneous group of veterans with colorectal cancer (CRC) at a tertiary care Veterans Affairs (VA) hospital. Methods: This is a retrospective review of 105 patients with colorectal malignancies treated with curative intent surgery at the VA Ann Arbor Healthcare System between January 2015 and January 2020. Patients with distant metastatic disease, neoadjuvant therapy, non-adenocarcinoma histology, or those receiving majority of care outside of the VHA were excluded. We examined BMI trends from one year prior to one year post surgery, rates of nutrition consults, and post-op complications defined as abnormal clinical developments such as, but not limited to, infection and delayed wound healing. Fisher’s exact test was used for analysis. Results: At time of CRC diagnosis, the mean age was 70.3 ± 9.1 and the median stage was T2N0. Surgical resections were 65% (n = 68) laparoscopic. Pre-op weight loss from 6 months prior to diagnosis to time of surgery was observed in the majority of patients (n = 47, 64%). Significant weight loss, defined as ≥3% weight reduction, was seen in 45% (n = 33) of patients. A quarter of patients were identified to have a low pre-op albumin of less than 3.5 (n = 25, 25%). Significant weight loss and low pre-op albumin were each independently associated with increased post-op complications (p < 0.01). Post-op weight loss was seen in 81% (n = 73) and 69% (n = 48) of patients at 30- and 60-days post-op, respectively, and was not associated with post-op complications. Inpatient post-op nutrition consultation was performed in 96% (n = 101) of patients; nutritional supplements were recommended in only 23% (n = 23) of cases. In patients with significant weight loss, pre-op nutrition evaluation was performed in 15% (n = 5) of cases and post-op outpatient nutrition follow up occurred in 18% (n = 6) of cases. Conclusions: 45% of patients had ≥3% weight loss 6 months prior to diagnosis of CRC and 25% of patients had low albumin levels. These led to greater post-operative complications. An intensive nutrition pre-habilitation program to address weight loss and low albumin prior to surgery for CRC is needed and may reduce associated complications.

scholarly journals A rapidly occurring compensatory decrease in physical activity counteracts diet-induced weight loss in female monkeys

2010 ◽  
Vol 298 (4) ◽  
pp. R1068-R1074 ◽  
Author(s):  
Elinor L. Sullivan ◽  
Judy L. Cameron
Keyword(s):  
Physical Activity ◽  
Weight Loss ◽  
Statistical Significance ◽  
The Body ◽  
Activity Level ◽  
Significant Weight Loss ◽  
Low Fat Diet ◽  
Primary Mechanism ◽  
Calorie Expenditure ◽  
Maximal Capacity

To study changes in energy balance occurring during the initial phases of dieting, 18 adult ovariectomized female monkeys were placed on a low-fat diet, and available calories were reduced by 30% compared with baseline consumption for 1 mo. Surprisingly, there was not significant weight loss; however, daily activity level (measured by accelerometry) decreased soon after diet initiation and reached statistical significance by the 4th wk of dieting (18 ± 5.6% decrease, P = 0.02). During a 2nd mo of dieting, available calories were reduced by 60% compared with baseline consumption, leading to 6.4 ± 1.7% weight loss and further suppression of activity. Metabolic rate decreased by 68 ± 12 kcal/day, with decreased activity accounting for 41 ± 9 kcal/day, and the metabolic activity of the weight lost accounting for 21 ± 5 kcal/day. A second group of three monkeys was trained to run on a treadmill for 1 h/day, 5 days/wk, at 80% maximal capacity, leading to increased calorie expenditure of 69.6 ± 10.7 kcal/day (equivalent to 49 kcal/day for 7 days). We conclude that a diet-induced decrease in physical activity is the primary mechanism the body uses to defend against diet-induced weight loss, and undertaking a level of exercise that is recommended to counteract weight gain and promote weight loss is able to prevent the compensatory decrease in physical activity-associated energy expenditure that slows diet-induced weight loss.

scholarly journals Roux-en-Y gastric bypass: limb length and weight loss

2014 ◽  
Vol 27 (suppl 1) ◽  
pp. 56-58 ◽  
Author(s):  
Antonio Carlos VALEZI ◽  
Antonio César MARSON ◽  
Rodrigo Alves MERGUIZO ◽  
Fernando Leão COSTA
Keyword(s):  
Body Mass Index ◽  
Weight Loss ◽  
Gastric Bypass ◽  
Body Mass ◽  
Total Weight ◽  
Total Weight Loss ◽  
Alimentary Limb ◽  
Biliopancreatic Limb ◽  
One Year ◽  
Group B

BACKGROUND: Roux-en-Y gastric bypass is a surgical technique widely used in the treatment of obesity. It is unclear, however, if the length of the biliopancreatic and alimentary limb interferes with the magnitude of weight loss. AIM: To evaluate if the length of these limbs is related to the percentage of weight loss one year after surgery. METHOD: One hundred and twenty obese people underwent surgery between 2009 and 2011. Patients were inserted into four groups: A) biliopancreatic limb with 50 cm length and alimentary limb with100 cm length; B) biliopancreatic limb with 50 cm length and alimentary limb with 150 cm length; C) biliopancreatic limb with 100 cm length and alimentary limb with100 cm length; D) biliopancreatic limb with 100 cm length and alimentary limb with150 cm length. Age, gender, body mass index and the percentage of total weight loss were analyzed. Data were collected preoperatively and one year after surgery. The groups were compared and weight loss compared between groups. RESULTS: The follow-up occurred in 78.3% of the sample. The composition of the groups was similar, with no statistical significance. The average age was 43 years in groups A, C and D and 42 years in group B. The female gender predominated in all groups (about 60% of the sample). The mean body mass index was 46 kg/m2 for groups A, C and D and 42 kg/m2 in group B. The percentage of weight loss was 33% for group A and 34% for groups B, C and D. There was no significant difference among groups. CONCLUSION: Different lengths of the biliopancreatic and alimentary limbs did not affect the percentage of total weight loss.

scholarly journals Remission of comorbidities, weight loss, and adverse events after sleeve gastrectomy and Roux-en-Y Gastric Bypass in patients with obesity

2021 ◽  
Vol 12 (3) ◽  
pp. 251-263
Author(s):  
Omar Thaher ◽  
Jamal Driouch ◽  
Martin Hukauf ◽  
Christine Stroh
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Adverse Events ◽  
Remission Rate ◽  
P Value ◽  
Extensive Literature ◽  
Treatment Of Obesity ◽  
One Year ◽  
Remission Of Comorbidities

Background: Despite the extensive literature on the outcome and impact of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on comorbidities and weight loss, clear evidence is still lacking. Our study aims to compare the short- and long-term efficacy and safety of the two procedures in patients with obesity. Methods: The primary endpoint of this retrospective registry study is to examine the adverse events after surgery, weight loss, and remission rate of comorbidities 12 months after surgery. Any result with a p-value of ≤ 5% corresponds to a significant outcome. Results: 27,882 patients had completed a one-year follow-up. 14,399 patients after SG and 13,483 after RYGB. The overall rate of intraoperative and postoperative complications was not significantly different between the two groups (overall p>5%). The %EWL was 62.4% in the SG group vs. 69.2% in the RYGB group; p<0.001. BMI reduction and mean weight loss were significantly different between the two groups in favor of SG. The RYGB group achieved significantly better remission of diabetes mellitus (T2DM; p<0.001), hypertension (28.8% vs. 23.5%; p < 0.001) and reflux 22.3% vs. 7.8%; p<0.001). Sleep apnea remission was similar between the two groups (10.2%; p<0.001). Conclusion: SG and RYGB are effective methods in the treatment of obesity. RYGB achieved better results in terms of remission of comorbidities and %EWL. However, further studies are needed to investigate the sustainability of weight loss and remission of comorbidities after both procedures.

scholarly journals Outcome of a one-year behavior therapy weight loss program

2014 ◽  
Vol 155 (30) ◽  
pp. 1196-1202
Author(s):  
Ildikó Papp ◽  
Edit Czeglédi ◽  
Ágnes Udvardy-Mészáros ◽  
Gabriella Vizin ◽  
Dóra Perczel Forintos
Keyword(s):  
Weight Loss ◽  
Behavior Therapy ◽  
Minimum Weight ◽  
Weight Loss Program ◽  
Eating Pattern ◽  
Self Help ◽  
Cost Effective Treatment ◽  
Treatment Of Obesity ◽  
One Year

Introduction: Treatment of obesity has become one of the most challenging issues. Aim: The aims of the authors were to present the results of standard behavior therapy weight loss program combined with self-help and the results of one-year follow-up. Method: The 24-week program involved 41 participants of which 33 subjects participated in the follow-up. Anthropometric data were obtained and the participants were asked to fill questionnaires (the 21 items Three Factor Eating Questionnair Revised 21 items; Physical Exercise: Steps of change [Short Form]. Results: 87.8% of participants achieved a minimum weight loss of 5% which is the rate expected in professional therapies for obesity. Significant changes in maladaptive eating pattern and an increase in the rate of regular exercise were observed. Significant association was found between the increase of cognitive restraint and the rate of weight loss during treatment. At one-year follow-up the majority of participants (75.8%) did keep their minimum weight loss of 5% and they showed significant change in eating pattern. Conclusions: The results suggest that standard behavior therapy extended with self-help elements may be a cost-effective treatment of obesity. Orv. Hetil., 2014, 155(30), 1196–1202.

Sign in / Sign up

Export Citation Format

Share Document